8 Ssali
11/9/06
16:20
Page 741
Antiviral Therapy 11:741–749
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial Francis Ssali 1, Wolfgang Stöhr 2, Paula Munderi 3, Andrew Reid 4, A Sarah Walker 2*, Diana M Gibb 2, Peter Mugyenyi 1, Cissy Kityo1, Heiner Grosskurth3, James Hakim4, Helen Byakwaga 5, Elly Katabira 5, Janet H Darbyshire 2 and Charles F Gilks6 on behalf of the DART Trial Team 1
Joint Clinical Research Centre, Kampala, Uganda MRC Clinical Trials Unit, London, UK 3 MRC Programme on AIDS/Uganda Virus Research Institute, Entebbe, Uganda 4 University of Zimbabwe, Harare, Zimbabwe 5 Academic Alliance, Mulago Hospital, Uganda 6 Imperial College, London, UK 2
*Corresponding author: Tel: +44 20 7670 4726; Fax +44 20 7670 4818; E-mail:
[email protected]
Objective: To describe the prevalence, incidence and predictors of severe anaemia in previously untreated symptomatic HIV-infected adults with CD4+ T-cells
